Endometrial stromal sarcoma with Cd56 expression: a case report

Endometrial stromal sarcoma (ESS) is a rare malignant tumour of the endometrium, accounts for less than 1% of all uterine malignancies. Routinely, it is diagnosed morphologically, supported by immunomarkers of CD10 and vimentin. CD56 is used widely in neuroendocrine tumour. In our current practice,...

Full description

Bibliographic Details
Main Authors: Azizan N, Hayati F, Madatang A, Abu Seman F
Format: Article
Language:English
Published: Pusat Perubatan Universiti Kebangsaan Malaysia 2018
Online Access:http://journalarticle.ukm.my/12555/
http://journalarticle.ukm.my/12555/1/7._azizan_n_et_al.pdf
_version_ 1848813034059857920
author Azizan N,
Hayati F,
Madatang A,
Abu Seman F,
author_facet Azizan N,
Hayati F,
Madatang A,
Abu Seman F,
author_sort Azizan N,
building UKM Institutional Repository
collection Online Access
description Endometrial stromal sarcoma (ESS) is a rare malignant tumour of the endometrium, accounts for less than 1% of all uterine malignancies. Routinely, it is diagnosed morphologically, supported by immunomarkers of CD10 and vimentin. CD56 is used widely in neuroendocrine tumour. In our current practice, CD56 is not used to support the diagnosis of ESS. We present a case of a postmenopausal lady with advanced ESS who had expression of CD56 upon immunohistochemical study.
first_indexed 2025-11-15T00:11:46Z
format Article
id oai:generic.eprints.org:12555
institution Universiti Kebangasaan Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T00:11:46Z
publishDate 2018
publisher Pusat Perubatan Universiti Kebangsaan Malaysia
recordtype eprints
repository_type Digital Repository
spelling oai:generic.eprints.org:125552019-02-14T21:32:17Z http://journalarticle.ukm.my/12555/ Endometrial stromal sarcoma with Cd56 expression: a case report Azizan N, Hayati F, Madatang A, Abu Seman F, Endometrial stromal sarcoma (ESS) is a rare malignant tumour of the endometrium, accounts for less than 1% of all uterine malignancies. Routinely, it is diagnosed morphologically, supported by immunomarkers of CD10 and vimentin. CD56 is used widely in neuroendocrine tumour. In our current practice, CD56 is not used to support the diagnosis of ESS. We present a case of a postmenopausal lady with advanced ESS who had expression of CD56 upon immunohistochemical study. Pusat Perubatan Universiti Kebangsaan Malaysia 2018 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/12555/1/7._azizan_n_et_al.pdf Azizan N, and Hayati F, and Madatang A, and Abu Seman F, (2018) Endometrial stromal sarcoma with Cd56 expression: a case report. Journal of Surgical Academia, 8 (1). pp. 36-38. ISSN 2231-7481 http://jsurgacad.com/toc/8/1
spellingShingle Azizan N,
Hayati F,
Madatang A,
Abu Seman F,
Endometrial stromal sarcoma with Cd56 expression: a case report
title Endometrial stromal sarcoma with Cd56 expression: a case report
title_full Endometrial stromal sarcoma with Cd56 expression: a case report
title_fullStr Endometrial stromal sarcoma with Cd56 expression: a case report
title_full_unstemmed Endometrial stromal sarcoma with Cd56 expression: a case report
title_short Endometrial stromal sarcoma with Cd56 expression: a case report
title_sort endometrial stromal sarcoma with cd56 expression: a case report
url http://journalarticle.ukm.my/12555/
http://journalarticle.ukm.my/12555/
http://journalarticle.ukm.my/12555/1/7._azizan_n_et_al.pdf